Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	SZTURZ Petr ADAM Zdeněk VAŠKŮ Vladimír FEIT Josef KREJČÍ Marta POUR Luděk HÁJEK Roman MAYER Jiří
Year of publication	2013
Type	Article in Periodical
Magazine / Source	LEUKEMIA & LYMPHOMA
MU Faculty or unit	Faculty of Medicine
Citation
Doi	http://dx.doi.org/10.3109/10428194.2012.738816
Field	Oncology and hematology
Keywords	SCLEROMYXEDEMA; DEXAMETHASONE; ADULTORUM; BUSCHKE; THALIDOMIDE; DISORDERS; PATIENT; DISEASE
Description	Scleredema is a rare scleroderma-like fi bromucinosis characterized by progressive thickening of the skin caused by excessive collagen and mucin depositions in the dermis. Various treatment regimens have been proposed, however with inconsistent outcomes. Herein we are the fi rst to report a complete dermatological and hematological remission in a patient with multiple myeloma associated scleredema after bortezomib-based chemotherapy.
Related projects:	Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií Nové diagnostické a klinické přístupy v onkologii Úloha genetických abnormalit ve vývoji a progresi prekancerózy monoklonální gamapatie nejasného významu Molekulární charakteristika centrozomálních abnormalit a jejich prognostický význam pro pacienty s mnohočetným myelomem